ViroSeq statistics

Tool stats & trends

Looking to identify usage trends or leading experts?


ViroSeq specifications


Unique identifier OMICS_32645
Name ViroSeq
Software type Application/Script
Interface Graphical user interface
Restrictions to use License purchase required
Operating system Unix/Linux
Computer skills Medium
Stability Stable
Maintained Yes


No version available

ViroSeq citations


Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV 1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48 week results of a randomized trial

PLoS One
PMCID: 5697828
PMID: 29161288
DOI: 10.1371/journal.pone.0187393

[…] notypic HIV-1 coreceptor tropism assay has been deposited in the repository with doi 10.17504/ Genotypic resistance to NRTIs, NNRTIs and PIs was determined using the Viroseq HIV-1 Genotyping System. […]


Implication of First Line Antiretroviral Therapy Choice on Second Line Options

PMCID: 5726477
PMID: 29255731
DOI: 10.1093/ofid/ofx233
call_split See protocol

[…] ith VL ≥1000 copies/mL) and on samples taken closest to the time of 2L switch (S2 sample). Drug resistance mutation assays for the S1 samples were conducted at the 3 laboratories in Nigeria using the ViroSeq HIV-1 Genotyping System 2.0 Assay (Abbot, Chicago, IL) or the American Type Culture Collection HIV-1 Drug Resistance Genotyping Kit (CDC, Atlanta, GA). Protease and reverse-transcriptase seque […]


High rate of HIV 1 drug resistance in treatment failure patients in Taiwan, 2009–2014

PMCID: 5652926
PMID: 29081666
DOI: 10.2147/IDR.S146584

[…] Resistance testing was performed on plasma samples using the ViroSeq™ HIV-1 Genotyping System version v2.8, according to the manufacturer’s instructions (Celera, Alameda, CA, USA). Antiretroviral resistance mutations were defined using the 2015 International An […]


Drug resistance patterns following pharmacy stock shortage in Nigerian Antiretroviral Treatment Program

PMCID: 5640939
PMID: 29029637
DOI: 10.1186/s12981-017-0184-5

[…] Plasma virus from patients in VF was genotyped in the reverse transcriptase (RT) and protease (PR) genes using the ViroSeq HIV-1 Genotyping System 2.0 Assay (Abbott, Chicago, IL). All sequence data were edited and analyzed to generate lists of mutations and polymorphisms. Mutations were categorized according to th […]


Epidemic dispersion of HIV and HCV in a population of co infected Romanian injecting drug users

PLoS One
PMCID: 5633171
PMID: 29016621
DOI: 10.1371/journal.pone.0185866

[…] luted in 25μl of water. Ten microliters of RNA were used for HIV genotyping. Reverse transcription and amplification of the HIV-1 pol gene (1301 nucleotides, HXB2: 2253–3554) were performed using the Viroseq HIV-1 Genotyping System (Celera Diagnostics, Alameda, CA) and sequenced with the ABI 3500 Genetic Analyzer (Applied Biosystems, Foster City, CA). The primary data were analysed using Sequencin […]


Six Highly Conserved Targets of RNAi Revealed in HIV 1 Infected Patients from Russia Are Also Present in Many HIV 1 Strains Worldwide

Mol Ther Nucleic Acids
PMCID: 5537207
PMID: 28918033
DOI: 10.1016/j.omtn.2017.07.010

[…] dignity in biomedical research in the member states of the Commonwealth of Independent States” (October 18, 2005).The RNA preparations were extracted individually from 500 μL of plasma samples using ViroSeq reagents (Celera Diagnostics) and then treated with DNase using a DNA-free kit (Ambion) as described previously., The concentration of RNA preparations was measured using a NanoDrop 2000.Five […]


Looking to check out a full list of citations?

ViroSeq institution(s)

ViroSeq reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review ViroSeq